Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina

This publication has 11 references indexed in Scilit:

• Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.
  The American Journal of Tropical Medicine and Hygiene, 1998
• Trypanosoma rangeliandTrypanosoma cruzi:Molecular Characterization of Genes Encoding Putative Calcium-Binding Proteins, Highly Conserved in Trypanosomatids
  Experimental Parasitology, 1996
• Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection
  The Lancet, 1996
• Treatment of chronic Chagas' disease with benznidazole: Clinical and serologic evolution of patients with long-term follow-up
  American Heart Journal, 1994
• Use of Trypanosoma Cruzi Purified Glycoprotein (GP57/51) or Trypomastigote-Shed Antigens to Assess Cure for Human Chagas' Disease
  The American Journal of Tropical Medicine and Hygiene, 1993
• Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993
• Tratamento da forma indeterminada da doença de Chagas com nifurtimox e benzonidazol
  Revista da Sociedade Brasileira de Medicina Tropical, 1990
• Criterion of cure of human Chagas' disease after specific chemotherapy: recent advances
  Memórias do Instituto Oswaldo Cruz, 1984
• Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.
  The Journal of Immunology, 1982